Literature DB >> 17415573

Telovelar approach: technical issues for large fourth ventricle tumors.

B J Rajesh1, B R M Rao, G Menon, M Abraham, H V Easwer, S Nair.   

Abstract

OBJECTS: Fourth ventricle is conventionally accessed via resection of the part of the vermis for total excision of the tumors at the expense of significant morbidity. Numerous avenues have been identified to minimize the morbidity; some of which include transforaminal, subtonsillar, telovelar approaches, etc. These approaches are devised on the basis that accurate dissection along the natural avascular planes will avoid injury to the important structures in this area minimizing morbidity. We attempt to emphasize the technique of telovelar approach and the problems encountered while employing this technique for excision of large fourth ventricle tumors.
MATERIALS AND METHODS: Fifteen patients with fourth ventricle tumors were operated during January to September 2005 at Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India. Fourteen of these cases were medulloblastomas, and one was ependymoma. All the patients were operated in prone oblique position via telovelar approach.
CONCLUSION: Clear understanding of the normal anatomy will help in meticulous dissection and will result in reduced morbidity. Significant incidence of postoperative ataxia and mutism is seen with this approach in large tumors, and this can be avoided by staged dissection of the uvulotonsillar cleft.

Entities:  

Mesh:

Year:  2007        PMID: 17415573     DOI: 10.1007/s00381-006-0295-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  7 in total

1.  Telovelar approach to the fourth ventricle: microsurgical anatomy.

Authors:  A C Mussi; A L Rhoton
Journal:  J Neurosurg       Date:  2000-05       Impact factor: 5.115

2.  Transcerebellomedullary fissure approach with special reference to methods of dissecting the fissure.

Authors:  T Matsushima; T Inoue; T Inamura; Y Natori; K Ikezaki; M Fukui
Journal:  J Neurosurg       Date:  2001-02       Impact factor: 5.115

3.  Comparison of the transvermian and telovelar approaches to the fourth ventricle.

Authors:  Necmettin Tanriover; Arthur J Ulm; Albert L Rhoton; Alexandre Yasuda
Journal:  J Neurosurg       Date:  2004-09       Impact factor: 5.115

4.  Quantification and comparison of telovelar and transvermian approaches to the fourth ventricle.

Authors:  Vivek R Deshmukh; Eberval Gadelha Figueiredo; Puspha Deshmukh; Neil R Crawford; Mark C Preul; Robert F Spetzler
Journal:  Neurosurgery       Date:  2006-04       Impact factor: 4.654

5.  Resection of fourth ventricle tumors without splitting the vermis: the cerebellomedullary fissure approach.

Authors:  J X Kellogg; J H Piatt
Journal:  Pediatr Neurosurg       Date:  1997-07       Impact factor: 1.162

6.  Subtonsillar-transcerebellomedullary approach to lesions involving the fourth ventricle, the cerebellomedullary fissure and the lateral brainstem.

Authors:  I M Ziyal; L N Sekhar; E Salas
Journal:  Br J Neurosurg       Date:  1999-06       Impact factor: 1.596

7.  Telovelar approach to the fourth ventricle: operative findings and results in 16 cases.

Authors:  K El-Bahy
Journal:  Acta Neurochir (Wien)       Date:  2005-02       Impact factor: 2.216

  7 in total
  18 in total

1.  Endoscopic telovelar approach to the fourth ventricle: anatomic study.

Authors:  Antonio Di Ieva; Mika Komatsu; Fuminari Komatsu; Manfred Tschabitscher
Journal:  Neurosurg Rev       Date:  2011-12-15       Impact factor: 3.042

2.  Exposure of the wide interior of the fourth ventricle without splitting the vermis: importance of cutting procedures for the tela choroidea.

Authors:  Toshio Matsushima; Hiroshi Abe; Masatou Kawashima; Tooru Inoue
Journal:  Neurosurg Rev       Date:  2012-04-12       Impact factor: 3.042

3.  Microsurgical anatomy of the foramen of Luschka in the cerebellopontine angle, and its vascular supply.

Authors:  Mansoor Sharifi; Ewa Ungier; Bogdan Ciszek; Pawel Krajewski
Journal:  Surg Radiol Anat       Date:  2009-02-04       Impact factor: 1.246

4.  Ascending vermian artery, branch of the V4 segment of the vertebral artery.

Authors:  Mugurel Constantin Rusu
Journal:  Surg Radiol Anat       Date:  2011-02-24       Impact factor: 1.246

Review 5.  Consensus paper on post-operative pediatric cerebellar mutism syndrome: the Iceland Delphi results.

Authors:  Thora Gudrunardottir; Angela T Morgan; Andrew L Lux; David A Walker; Karin S Walsh; Elizabeth M Wells; Jeffrey H Wisoff; Marianne Juhler; Jeremy D Schmahmann; Robert F Keating; Coriene Catsman-Berrevoets
Journal:  Childs Nerv Syst       Date:  2016-05-03       Impact factor: 1.475

Review 6.  Evolution of cerebellomedullary fissure opening: its effects on posterior fossa surgeries from the fourth ventricle to the brainstem.

Authors:  Toshio Matsushima; Ken Matsushima; James Rutka
Journal:  Neurosurg Rev       Date:  2020-04-12       Impact factor: 3.042

7.  Cerebellar Mutism Syndrome After Posterior Fossa Surgery: A Report of Two Cases of Pilocytic Astrocytoma.

Authors:  Hasan Burak Gündüz; Mustafa İlker Kuntay Yassa; Ali Ender Ofluoğlu; Lütfü Postalci; Erhan Emel
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

8.  Analysis of single-staged resection of a fourth ventricular tumor via a combined infratentorial-supracerebellar and telovelar approach: Case report and review of the literature.

Authors:  Christoph J Griessenauer; R Shane Tubbs; Aaron A Cohen-Gadol
Journal:  Int J Surg Case Rep       Date:  2013-07-16

Review 9.  Surgical resection of fourth ventricular ependymomas: case series and technical nuances.

Authors:  Ethan A Winkler; Harjus Birk; Michael Safaee; John K Yue; John F Burke; Jennifer A Viner; Melike Pekmezci; Arie Perry; Manish K Aghi; Mitchel S Berger; Michael W McDermott
Journal:  J Neurooncol       Date:  2016-10-24       Impact factor: 4.130

Review 10.  Telovelar surgical approach.

Authors:  Michael G Z Ghali
Journal:  Neurosurg Rev       Date:  2019-12-05       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.